Liver Transplant Research Today is a free monthly online journal that collates and summarizes the latest research about Liver Transplant, including details on risks, prognosis, procedure, surgery, organ donation.

Volume 1 (2005), Issue 6 (June)

1. Traumatic stress symptoms in adolescent organ transplant recipients.
   Pediatrics, 115(6): 1640-4. [Abstract] [Full-text]
2. Impact of prior portosystemic shunt procedures on outcome of liver transplantation.
   Surgery, 137(6): 620-5. [Abstract] [Full-text]
3. Interventional radiology in liver transplantation.
   Cardiovasc Intervent Radiol, 28(3): 271-83. [Abstract] [Full-text]
4. Liver recipients harbouring anti-donor preformed lymphocytotoxic antibodies exhibit a poor allograft survival at the first year after transplantation: experience of one centre.
   Transpl Immunol, 14(2): 91-7. [Abstract] [Full-text]
5. No association between tumor necrosis factor-alpha production and gene polymorphisms among inbred rat strains.
   Transpl Immunol, 14(2): 77-82. [Abstract] [Full-text]
6. Intraoperative blood loss during living donor liver transplantation: an analysis of 635 recipients at a single center.
   Transfusion, 45(6): 879-84. [Abstract] [Full-text]
7. Tailoring the type of donor hepatectomy for adult living donor liver transplantation.
   Am J Transplant, 5(7): 1694-703. [Abstract] [Full-text]
8. Split-liver transplantation: results of statewide usage of the right trisegmental graft.
   Am J Transplant, 5(7): 1652-9. [Abstract] [Full-text]
9. Split-liver transplantation using the left lateral segment: a collaborative sharing experience between two distant centers.
   Am J Transplant, 5(7): 1646-51. [Abstract] [Full-text]
10. Is it right to promote living donor liver transplantation for fulminant hepatic failure in pediatric recipients?
    Am J Transplant, 5(7): 1587-91. [Abstract] [Full-text]
11. Use of a mechanical thrombectomy device to recanalize a subacutely occluded aortohepatic bypass after orthotopic liver transplantation.
    J Endovasc Ther, 12(3): 401-4. [Abstract] [Full-text]
12. Transjugular intrahepatic portosystemic shunt in a living donor left lateral segment liver transplant recipient: technical considerations.
    J Vasc Interv Radiol, 16(6): 873-7. [Abstract] [Full-text]
13. Hepatic artery stenosis in liver transplant recipients: primary treatment with percutaneous transluminal angioplasty.
    J Vasc Interv Radiol, 16(6): 795-805. [Abstract] [Full-text]
14. Identification of expandable human hepatic progenitors which differentiate into mature hepatic cells in vivo.
    Gut, 54(7): 972-9. [Abstract] [Full-text]
15. Successful treatment with tenofovir in a child C cirrhotic patient with lamivudine-resistant hepatitis B virus awaiting liver transplantation. Post-transplant results.
    Transpl Int, 18(7): 879-83. [Abstract] [Full-text]
16. OKT3 and ganciclovir treatments are possibly related to the presence of Epstein-Barr virus in serum after liver transplantation.
    Transpl Int, 18(7): 835-43. [Abstract] [Full-text]
17. Left and right lobe split-liver transplantation for two paediatric recipients from a 9-year-old donor.
    Transpl Int, 18(7): 811-5. [Abstract] [Full-text]
18. Living donor liver transplantation for primary biliary cirrhosis: retrospective analysis of 50 patients in a single center.
    Transpl Int, 18(7): 794-9. [Abstract] [Full-text]
19. Use of Neoral C monitoring: a European consensus.
    Transpl Int, 18(7): 768-78. [Abstract] [Full-text]
20. Applicability of adult-to-adult living donor liver transplantation.
    J Hepatol, 43(1): 104-9. [Abstract] [Full-text]
21. Combined treatment with pegylated interferon (alpha-2b) and ribavirin in the acute phase of hepatitis C virus recurrence after liver transplantation.
    J Hepatol, 43(1): 53-9. [Abstract] [Full-text]
22. Percutaneous transluminal angioplasty of an occluded surgical splenorenal shunt in a 4-year-old child after liver transplantation.
    Pediatr Radiol, 35(7): 688-90. [Abstract] [Full-text]
23. Relaxin as an additional protective substance in preserving and reperfusion solution for liver transplantation, shown in a model of isolated perfused rat liver.
    Ann N Y Acad Sci, 1041: 434-40. [Abstract] [Full-text]
24. Hepatic natural killer and natural killer T cells markedly decreased in two cases of drug-induced fulminant hepatic failure rescued by living donor liver transplantation.
    J Gastroenterol Hepatol, 20(7): 1126-30. [Abstract] [Full-text]
25. Plasma propofol concentrations during orthotopic liver transplantation.
    Acta Anaesthesiol Scand, 49(6): 804-10. [Abstract] [Full-text]
26. Survival of liver transplant candidates with acute renal failure receiving renal replacement therapy.
    Kidney Int, 68(1): 362-70. [Abstract] [Full-text]
27. Immunosuppression by combined use of cyclosporine and resveratrol in a rat liver transplantation model.
    Transplant Proc, 37(5): 2354-9. [Abstract] [Full-text]
28. Evaluation of intraoperative infusion solution using a complete anhepatic model in baby pigs.
    Transplant Proc, 37(5): 2341-6. [Abstract] [Full-text]
29. A rat model of chronic allograft liver rejection.
    Transplant Proc, 37(5): 2327-32. [Abstract] [Full-text]
30. Liver transplant combined with heart transplant in severe heterozygous hypercholesterolemia: report of the first case and review of the literature.
    Transplant Proc, 37(5): 2250-2. [Abstract] [Full-text]
31. Factors in association with sepsis after liver transplantation: the Hungarian experience.
    Transplant Proc, 37(5): 2227-8. [Abstract] [Full-text]
32. Liver failure in transplanted liver due to Amanita falloides.
    Transplant Proc, 37(5): 2224-6. [Abstract] [Full-text]
33. Clinicopathological review of 18 cases of liver allografts lost due to bile duct necrosis.
    Transplant Proc, 37(5): 2221-3. [Abstract] [Full-text]
34. Liver transplantation for familial amyloid polyneuropathy non-VAL30MET variants: are cardiac complications influenced by prophylactic pacing and immunosuppressive weaning?
    Transplant Proc, 37(5): 2214-20. [Abstract] [Full-text]
35. Preoperative dobutamine stress echocardiography, intraoperative events, and intraoperative myocardial injury in liver transplantation.
    Transplant Proc, 37(5): 2209-13. [Abstract] [Full-text]
36. Peginterferon and ribavirin in patients with HCV cirrhosis after liver transplantation.
    Transplant Proc, 37(5): 2207-8. [Abstract] [Full-text]
37. De novo hepatocellular carcinoma in a liver allograft associated with recurrent hepatitis B.
    Transplant Proc, 37(5): 2205-6. [Abstract] [Full-text]
38. Is hepatitis B immunoglobulin prophylaxis needed for liver transplantation in the era of new antivirals?
    Transplant Proc, 37(5): 2200-4. [Abstract] [Full-text]
39. Hepatic angiosarcoma and liver transplantation: case report and literature review.
    Transplant Proc, 37(5): 2195-9. [Abstract] [Full-text]
40. Successful treatment of liver transplant-associated Kaposi's sarcoma with long-term vincristine.
    Transplant Proc, 37(5): 2188-9. [Abstract] [Full-text]
41. Successful use of sirolimus in a patient with bulky ovarian metastasis of hepatocellular carcinoma after liver transplantation.
    Transplant Proc, 37(5): 2185-7. [Abstract] [Full-text]
42. Orthotopic liver transplantation for incurable alveolar echinococcosis: report of five cases from west China.
    Transplant Proc, 37(5): 2181-4. [Abstract] [Full-text]
43. Treatment of steroid-resistant acute liver transplant rejection with basiliximab.
    Transplant Proc, 37(5): 2179-80. [Abstract] [Full-text]
44. MELD scores do not predict patient morbidity while on the liver transplant waiting list.
    Transplant Proc, 37(5): 2174-8. [Abstract] [Full-text]
45. Mortality while awaiting liver retransplantation: predictability of MELD scores.
    Transplant Proc, 37(5): 2172-3. [Abstract] [Full-text]
46. What is the best immunosuppression in living donor liver transplantation?
    Transplant Proc, 37(5): 2169-71. [Abstract] [Full-text]
47. Liver transplant with portocaval hemitransposition: blood supply with only hepatic artery is possible?
    Transplant Proc, 37(5): 2163-5. [Abstract] [Full-text]
48. Orthotopic liver transplantation with vena cava preservation in cirrhotic patients: is systematic temporary portacaval anastomosis a justified procedure?
    Transplant Proc, 37(5): 2159-62. [Abstract] [Full-text]
49. Effect of hepatitis C infection on tacrolimus doses and blood levels in liver transplantation recipients.
    Aliment Pharmacol Ther, 22(1): 37-44. [Abstract] [Full-text]
50. The outcome of surgical resection versus assignment to the liver transplant waiting list for hepatocellular carcinoma.
    Ann Surg Oncol, 12(7): 552-60. [Abstract] [Full-text]
51. Hepatofugal portal flow due to acute cellular rejection.
    Abdom Imaging, 30(3): 303-5. [Abstract] [Full-text]
52. A novel approach to managing variation: outpatient therapeutic monitoring of calcineurin inhibitor blood levels in liver transplant recipients.
    J Pediatr, 146(6): 744-50. [Abstract] [Full-text]
53. Vascular closure staples for portal vein reconstruction in living-donor liver transplantation.
    Am J Surg, 190(1): 65-8. [Abstract] [Full-text]
54. Oxidative mitochondrial DNA damage and deletion in hepatocytes of rejecting liver allografts in rats: role of TNF-alpha.
    Hepatology, 42(1): 208-15. [Abstract] [Full-text]
55. Hepatic targeting of transplanted liver sinusoidal endothelial cells in intact mice.
    Hepatology, 42(1): 140-8. [Abstract] [Full-text]
56. A comparison of transfusion requirements between living donation and cadaveric donation liver transplantation: relationship to model of end-stage liver disease score and baseline coagulation status.
    Anesth Analg, 101(1): 30-7, table of contents. [Abstract] [Full-text]
57. Practice of adult liver transplantation in Italy. Recommendations of the Italian Association for the Study of the Liver (A.I.S.F.).
    Dig Liver Dis, 37(7): 461-7. [Abstract] [Full-text]
58. Systematic review and validation of prognostic models in liver transplantation.
    Liver Transpl, 11(7): 814-25. [Abstract] [Full-text]
59. Liver transplantation for cardiac failure in patients with hereditary hemorrhagic telangiectasia.
    Liver Transpl, 11(7): 834-8. [Abstract] [Full-text]
60. Pharmacogenetic association with adverse drug reactions to azathioprine immunosuppressive therapy following liver transplantation.
    Liver Transpl, 11(7): 826-33. [Abstract] [Full-text]
61. Liver transplantation for chronic hepatitis B with lamivudine-resistant YMDD mutant using add-on adefovir dipivoxil plus lamivudine.
    Liver Transpl, 11(7): 807-13. [Abstract] [Full-text]
62. Critical analysis of the pediatric end-stage liver disease scoring system: a single center experience.
    Liver Transpl, 11(7): 788-95. [Abstract] [Full-text]
63. Changes in oxyhemoglobin dissociation curve in intrabdominal organs during pig experimental orthotopic liver transplantation.
    Liver Transpl, 11(7): 760-6. [Abstract] [Full-text]
64. Mycophenolate mofetil combination therapy improves long-term outcomes after liver transplantation in patients with and without hepatitis C.
    Liver Transpl, 11(7): 750-9. [Abstract] [Full-text]
65. Liver transplantation for HCV-related cirrhosis in a patient with gastric mucosa-associated lymphoma (MALToma) pretreated with rituximab.
    Liver Transpl, 11(7): 839-42. [Abstract] [Full-text]
66. "All-in-one" imaging protocols for the evaluation of potential living liver donors: comparison of magnetic resonance imaging and multidetector computed tomography.
    Liver Transpl, 11(7): 776-87. [Abstract] [Full-text]
67. Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma.
    Liver Transpl, 11(7): 767-75. [Abstract] [Full-text]
68. Right hepatic lobe donation adversely affects donor life insurability up to one year after donation.
    Liver Transpl, 11(7): 843-7. [Abstract] [Full-text]
69. Tissue-engineered patch for the reconstruction of inferior vena cava during living-donor liver transplantation.
    J Gastrointest Surg, 9(6): 789-93. [Abstract] [Full-text]
70. Severe hypogammaglobulinemia associated with hepatic vein stenosis causes cytomegalovirus infection after living-related liver transplantation.
    Transpl Infect Dis, 7(1): 41-4. [Abstract] [Full-text]
71. Human herpesvirus-8-related Kaposi's sarcoma after liver transplantation successfully treated with cidofovir and liposomal daunorubicin.
    Transpl Infect Dis, 7(1): 34-7. [Abstract] [Full-text]
72. Cryptococcosis after living donor liver transplantation: report of three cases.
    Transpl Infect Dis, 7(1): 26-9. [Abstract] [Full-text]
73. Glucose and lipid metabolism after liver transplantation in inbred rats: consequences of hepatic denervation.
    Metabolism, 54(7): 881-90. [Abstract] [Full-text]
74. Treatment of hepatic venous outflow obstruction after piggyback liver transplantation.
    Radiology, 236(1): 352-9. [Abstract] [Full-text]

© 2005-2008 Liver Transplant Research Today. All Rights Reserved.